Chiome Bioscience Inc.
Announcement of Monthly Exercise Status of Stock Acquisition Rights (With Exercise Price Adjustment Clause) and Completion of Rights Exercise
Disclosure of monthly exercise status for stock acquisition rights (with an exercise price adjustment clause). As of August 12, 2026, all issued stock acquisition rights have been exercised. For the target month, a total of 713,700 shares were issued, 7,137 stock acquisition rights were exercised (5.25% of the total issued), and unexercised remaining shares were 0.
Key Figures
- Number of shares issued during the target month: 713,700 shares
- Number of stock acquisition rights exercised: 7,137 units
- Unexercised remaining shares: 0 shares
AI要約
Section Heading
This is a monthly notice of the exercise status and completion of exercise of stock acquisition rights (with exercise price adjustment clause). As of August 12, 2026, all issued stock acquisition rights have been exercised. For the target month, 713,700 shares were issued, 7,137 stock acquisition rights were exercised, and the exercise rate against the issued total was about 1.05%, with 0 shares remaining unexercised.
Section 2 Heading
For the exercise date details, on each date from August 3 to August 12, issued shares and exercise price are shown; there was no exercise on August 4, and other days saw multiple exercises. The total number of listed shares for the target month was 68,053,800 shares, the total issued ordinary shares was 81,150,000 shares, and treasury stock was 22,819 shares. This disclosure involves dynamic movements of treasury stock, so dilutive impact is expected to be limited.
Kaioom Bioscience Inc.
Company overview · Stock price · Financial data · All IR
